These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32104990)

  • 21. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
    Zelinka T; Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Reynolds JC; Ling A; Eisenhofer G; Lazúrová I; Adams KT; Whatley MA; Widimsky J; Pacak K
    Endocr Relat Cancer; 2008 Mar; 15(1):311-23. PubMed ID: 18310297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroblastoma stage 4S with 123I-MIBG-positive bone marrow involvement.
    Hufnagel M; Claviez A; Czech N; Schmidt M; Hero B
    Pediatr Blood Cancer; 2006 Feb; 46(2):264-5. PubMed ID: 16078224
    [No Abstract]   [Full Text] [Related]  

  • 23. Transient enhanced uptake of 123I-metaiodobenzylguanidine in the contralateral adrenal region after resection of an adrenal pheochromocytoma.
    Boersma HH; Wensing JW; Kho TL; de Brauw LM; Liem IH; van Kroonenburgh MJ
    N Engl J Med; 2000 May; 342(19):1450-1. PubMed ID: 10809616
    [No Abstract]   [Full Text] [Related]  

  • 24. Complete remission of metastatic pheochromocytoma in
    Sugino T; Ando R; Unno R; Iida K; Naiki T; Hamamoto S; Mizuno K; Okada A; Umemoto Y; Kawai N; Tozawa K; Hayashi Y; Inaki A; Kayano D; Kinuya S; Yasui T
    BMC Res Notes; 2017 Dec; 10(1):750. PubMed ID: 29258609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remarkable improvement of myocardial metaiodobenzylguanidine uptake after surgery in a patient with pheochromocytoma-a case report.
    Konno T; Araki T; Soma R; Takimoto H; Tofuku Y; Shimizu M
    Angiology; 2004; 55(5):565-7. PubMed ID: 15378121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas.
    van der Harst E; de Herder WW; Bruining HA; Bonjer HJ; de Krijger RR; Lamberts SW; van de Meiracker AH; Boomsma F; Stijnen T; Krenning EP; Bosman FT; Kwekkeboom DJ
    J Clin Endocrinol Metab; 2001 Feb; 86(2):685-93. PubMed ID: 11158032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Usefulness of intraoperative 123I-MIBG during reoperation for malignant pheochromocytoma: a case report].
    Brunaud L; Cormier L; Ayav A; Marchal F; Olivier P; Bresler L; Boissel P
    Ann Chir; 2002 Mar; 127(3):225-7. PubMed ID: 11933640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression.
    Fottner C; Helisch A; Anlauf M; Rossmann H; Musholt TJ; Kreft A; Schadmand-Fischer S; Bartenstein P; Lackner KJ; Klöppel G; Schreckenberger M; Weber MM
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2800-10. PubMed ID: 20371665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MIBG negative pheochromocytoma.
    Mehta N; Paniker V; Shah A
    J Assoc Physicians India; 2010 Mar; 58():198-9. PubMed ID: 20848824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 123I-MIBG, 18F-DOPA and 18F-FDG in a patient with MEN2 syndrome and recurrent pheochromocytoma.
    Cuenca-Cuenca JI; Marín-Oyaga VA; Borrego-Dorado I; Navarro-González E; Martos-Martínez JM; Vázquez-Albertino R
    Rev Esp Med Nucl Imagen Mol; 2013; 32(4):263-5. PubMed ID: 23434017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: comparison with CT and MRI.
    Maurea S; Cuocolo A; Reynolds JC; Tumeh SS; Begley MG; Linehan WM; Norton JA; Walther MM; Keiser HR; Neumann RD
    J Nucl Med; 1993 Feb; 34(2):173-9. PubMed ID: 8381474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FDG PET in the evaluation of phaeochromocytoma: a correlative study with MIBG scintigraphy and Ki-67 proliferative index.
    Lin M; Wong V; Yap J; Jin R; Leong P; Campbell P
    Clin Imaging; 2013; 37(6):1084-8. PubMed ID: 24035263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonmosaic somatic HIF2A mutations associated with late onset polycythemia-paraganglioma syndrome: Newly recognized subclass of polycythemia-paraganglioma syndrome.
    Pang Y; Gupta G; Jha A; Yue X; Wang H; Huynh TT; Li A; Li L; Baker E; Chew E; Feelders RA; Korpershoek E; Zhuang Z; Yang C; Pacak K
    Cancer; 2019 Apr; 125(8):1258-1266. PubMed ID: 30644531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The utility of metaiodobenzylguanidine single photon emission computed tomography/computed tomography (MIBG SPECT/CT) for the diagnosis of pheochromocytoma.
    Meyer-Rochow GY; Schembri GP; Benn DE; Sywak MS; Delbridge LW; Robinson BG; Roach PJ; Sidhu SB
    Ann Surg Oncol; 2010 Feb; 17(2):392-400. PubMed ID: 19949879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tc-99m MIBG imaging in a huge clinically silent pheochromocytoma with cystic degeneration and massive hemorrhage.
    Suga K; Motoyama K; Hara A; Kume N; Ariga M; Matsunaga N
    Clin Nucl Med; 2000 Oct; 25(10):796-800. PubMed ID: 11043719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose (123)I-metaiodobenzylguanidine diagnostic scan is inferior to (131)I-metaiodobenzylguanidine posttreatment scan in detection of malignant pheochromocytoma and paraganglioma.
    Kayano D; Taki J; Fukuoka M; Wakabayashi H; Inaki A; Nakamura A; Kinuya S
    Nucl Med Commun; 2011 Oct; 32(10):941-6. PubMed ID: 21876405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The usefulness of [131I]-metaiodobenzylguanidine ([131I]-MIBG) scintigraphy performed one week after administration in diagnosing pheochromocytoma.
    Takahashi N; Suzuki T; Yamaya K; Funyu T
    Int J Urol; 1999 Jul; 6(7):331-6. PubMed ID: 10445301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumour size: the only predictive factor for 131I MIBG uptake in phaeochromocytoma and paraganglioma.
    Nguyen HH; Proye CA; Carnaille B; Combemale F; Pattou FN; Huglo D
    Aust N Z J Surg; 1999 May; 69(5):350-3. PubMed ID: 10353549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inadvertent intra-arterial injection of (123)I-MIBG in a patient with metastatic pheochromocytoma.
    Lohrmann C; Carrasquillo JA
    Clin Nucl Med; 2014 Feb; 39(2):217-8. PubMed ID: 24321830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre- and post-treatment distribution pattern of 123I-MIBG in patients with phaeochromocytomas and paragangliomas.
    Sinclair AJ; Bomanji J; Harris P; Ross G; Besser GM; Britton KE
    Nucl Med Commun; 1989 Aug; 10(8):567-76. PubMed ID: 2812639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.